NCT02950987View on ClinicalTrials.gov

Screening With Whole Body MRI For Detection Of Primary Tumors In Children And Adults With Li-Fraumeni Syndrome (LFS) And Other Cancer Predisposition Syndromes

NAActive, not recruitingINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Li-Fraumeni Syndrome

Interventions

DEVICE

Whole Body MRI

Trial Locations (3)

10065

Memorial Sloan-Kettering Cancer Center, New York

19104

Children's Hospital of Philadelphia, Philadelphia

02115

Dana Farber Cancer Institute, Boston

All Listed Sponsors

lead

Dana-Farber Cancer Institute

OTHER

NCT02950987 - Screening With Whole Body MRI For Detection Of Primary Tumors In Children And Adults With Li-Fraumeni Syndrome (LFS) And Other Cancer Predisposition Syndromes | Biotech Hunter | Biotech Hunter